Youri van Waardenburg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Youri van Waardenburg has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Amanda Fabra-García
Radboud University Medical Centre, Department of Medical Microbiology, Nijmegen, The Netherlands
1 shared publication - Annie Shu-Ping Yang
Leiden University Centre for Infectious Diseases, Leiden University Medical Centre; Leiden, The Netherlands
1 shared publication - Geert-Jan van Gemert
Radboudumc Afdeling Medische Microbiologie, Nijmegen, Gelderland, The Netherlands
1 shared publication - Kjerstin Lanke
Radboudumc Afdeling Medische Microbiologie, Nijmegen, Gelderland, The Netherlands
1 shared publication - Marije C. Behet
Radboud University Medical Centre, Department of Medical Microbiology, Nijmegen, The Netherlands
1 shared publication - Matthijs M. Jore
Radboud University Medical Center
1 shared publication
Latest Publications
- Open Access
- 22 March 2022
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 7 (6)
Human antibodies against noncircumsporozoite proteins block Plasmodium falciparum parasite development in hepatocytes
Sporozoite-based approaches currently represent the most effective vaccine strategies for induction of sterile protection against Plasmodium falciparum ( Pf ) malaria. Clinical development of subunit vaccines is almost exclusively centered on the circum-sporozoite protein (CSP), an abundantly expressed protein on the sporozoite membrane. Anti-CSP antibodies are able to block sporozoite invasion and development in human hepatocytes and subsequently prevent clinical malaria. Here, we have investigated whether sporozoite-induced human antibodies with specificities different from CSP can reduce Pf- liver stage development. IgG preparations were obtained from 12 volunteers inoculated with a protective immunization regime of whole sporozoites under chloroquine prophylaxis. These IgGs were depleted for CSP specificity by affinity chromatography. Recovered non-CSP antibodies were tested for sporozoite membrane binding and for functional inhibition of sporozoite invasion of a human hepatoma cell line and hepatocytes both in vitro and in vivo. Postimmunization IgGs depleted for CS specificity of 9 of 12 donors recognized sporozoite surface antigens. Samples from 5 of 12 donors functionally reduced parasite-liver cell invasion or development using the hepatoma cell line HC-04 and FRG-huHep mice containing human liver cells. The combined data provide clear evidence that non-CSP proteins, as yet undefined, do represent antibody targets for functional immunity against Pf parasites responsible for malaria.
- 22 March 2022
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 7 (6)
Open AccessHuman antibodies against noncircumsporozoite proteins block Plasmodium falciparum parasite development in hepatocytes
Sporozoite-based approaches currently represent the most effective vaccine strategies for induction of sterile protection against Plasmodium falciparum ( Pf ) malaria. Clinical development of subunit vaccines is almost exclusively centered on the circum-sporozoite protein (CSP), an abundantly expressed protein on the sporozoite membrane. Anti-CSP antibodies are able to block sporozoite invasion and development in human hepatocytes and subsequently prevent clinical malaria. Here, we have investigated whether sporozoite-induced human antibodies with specificities different from CSP can reduce Pf- liver stage development. IgG preparations were obtained from 12 volunteers inoculated with a protective immunization regime of whole sporozoites under chloroquine prophylaxis. These IgGs were depleted for CSP specificity by affinity chromatography. Recovered non-CSP antibodies were tested for sporozoite membrane binding and for functional inhibition of sporozoite invasion of a human hepatoma cell line and hepatocytes both in vitro and in vivo. Postimmunization IgGs depleted for CS specificity of 9 of 12 donors recognized sporozoite surface antigens. Samples from 5 of 12 donors functionally reduced parasite-liver cell invasion or development using the hepatoma cell line HC-04 and FRG-huHep mice containing human liver cells. The combined data provide clear evidence that non-CSP proteins, as yet undefined, do represent antibody targets for functional immunity against Pf parasites responsible for malaria.